The treatment of hypertension during pregnancy

When should blood pressure medications be started?

Dawn C. Scantlebury, Gary Lee Schwartz, Letitia A. Acquah, Wendy M. White, Marvin Moser, Vesna D Garovic

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Hypertensive pregnancy disorders (HPD) are important causes of maternal and fetal morbidity and mortality worldwide. In addition, a history of HPD has been associated with an increased risk for maternal cardiovascular disease later in life, possibly because of irreversible vascular and metabolic changes that persist beyond the affected pregnancies. Therefore, treatment of HPD may not only improve immediate pregnancy outcomes, but also maternal long-term cardiovascular health. Unlike the recommendations for hypertension treatment in the general population, treatment recommendations for HPD have not changed substantially for more than 2 decades. This is particularly true for mild to moderate hypertension in pregnancy, defined as a blood pressure of 140-159/90-109 mm Hg. This review focuses on the goals of therapy, treatment strategies, and new developments in the field of HPD that should be taken into account when considering blood pressure targets and pharmacologic options for treatment of hypertension in pregnant women.

Original languageEnglish (US)
Article number412
JournalCurrent Cardiology Reports
Volume15
Issue number11
DOIs
StatePublished - 2013

Fingerprint

Blood Pressure
Hypertension
Pregnancy
Mothers
Therapeutics
Fetal Mortality
Reproductive History
Pregnancy Outcome
Blood Vessels
Pregnant Women
Cardiovascular Diseases
Morbidity
Health
Population

Keywords

  • Antihypertensive agents
  • Blood pressure medications
  • Cardiovascular diseases in women
  • Hypertension
  • Pregnancy induced
  • Treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The treatment of hypertension during pregnancy : When should blood pressure medications be started? / Scantlebury, Dawn C.; Schwartz, Gary Lee; Acquah, Letitia A.; White, Wendy M.; Moser, Marvin; Garovic, Vesna D.

In: Current Cardiology Reports, Vol. 15, No. 11, 412, 2013.

Research output: Contribution to journalArticle

Scantlebury, Dawn C. ; Schwartz, Gary Lee ; Acquah, Letitia A. ; White, Wendy M. ; Moser, Marvin ; Garovic, Vesna D. / The treatment of hypertension during pregnancy : When should blood pressure medications be started?. In: Current Cardiology Reports. 2013 ; Vol. 15, No. 11.
@article{7232eef7d52f45228302c1a4a780902c,
title = "The treatment of hypertension during pregnancy: When should blood pressure medications be started?",
abstract = "Hypertensive pregnancy disorders (HPD) are important causes of maternal and fetal morbidity and mortality worldwide. In addition, a history of HPD has been associated with an increased risk for maternal cardiovascular disease later in life, possibly because of irreversible vascular and metabolic changes that persist beyond the affected pregnancies. Therefore, treatment of HPD may not only improve immediate pregnancy outcomes, but also maternal long-term cardiovascular health. Unlike the recommendations for hypertension treatment in the general population, treatment recommendations for HPD have not changed substantially for more than 2 decades. This is particularly true for mild to moderate hypertension in pregnancy, defined as a blood pressure of 140-159/90-109 mm Hg. This review focuses on the goals of therapy, treatment strategies, and new developments in the field of HPD that should be taken into account when considering blood pressure targets and pharmacologic options for treatment of hypertension in pregnant women.",
keywords = "Antihypertensive agents, Blood pressure medications, Cardiovascular diseases in women, Hypertension, Pregnancy induced, Treatment",
author = "Scantlebury, {Dawn C.} and Schwartz, {Gary Lee} and Acquah, {Letitia A.} and White, {Wendy M.} and Marvin Moser and Garovic, {Vesna D}",
year = "2013",
doi = "10.1007/s11886-013-0412-0",
language = "English (US)",
volume = "15",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "11",

}

TY - JOUR

T1 - The treatment of hypertension during pregnancy

T2 - When should blood pressure medications be started?

AU - Scantlebury, Dawn C.

AU - Schwartz, Gary Lee

AU - Acquah, Letitia A.

AU - White, Wendy M.

AU - Moser, Marvin

AU - Garovic, Vesna D

PY - 2013

Y1 - 2013

N2 - Hypertensive pregnancy disorders (HPD) are important causes of maternal and fetal morbidity and mortality worldwide. In addition, a history of HPD has been associated with an increased risk for maternal cardiovascular disease later in life, possibly because of irreversible vascular and metabolic changes that persist beyond the affected pregnancies. Therefore, treatment of HPD may not only improve immediate pregnancy outcomes, but also maternal long-term cardiovascular health. Unlike the recommendations for hypertension treatment in the general population, treatment recommendations for HPD have not changed substantially for more than 2 decades. This is particularly true for mild to moderate hypertension in pregnancy, defined as a blood pressure of 140-159/90-109 mm Hg. This review focuses on the goals of therapy, treatment strategies, and new developments in the field of HPD that should be taken into account when considering blood pressure targets and pharmacologic options for treatment of hypertension in pregnant women.

AB - Hypertensive pregnancy disorders (HPD) are important causes of maternal and fetal morbidity and mortality worldwide. In addition, a history of HPD has been associated with an increased risk for maternal cardiovascular disease later in life, possibly because of irreversible vascular and metabolic changes that persist beyond the affected pregnancies. Therefore, treatment of HPD may not only improve immediate pregnancy outcomes, but also maternal long-term cardiovascular health. Unlike the recommendations for hypertension treatment in the general population, treatment recommendations for HPD have not changed substantially for more than 2 decades. This is particularly true for mild to moderate hypertension in pregnancy, defined as a blood pressure of 140-159/90-109 mm Hg. This review focuses on the goals of therapy, treatment strategies, and new developments in the field of HPD that should be taken into account when considering blood pressure targets and pharmacologic options for treatment of hypertension in pregnant women.

KW - Antihypertensive agents

KW - Blood pressure medications

KW - Cardiovascular diseases in women

KW - Hypertension

KW - Pregnancy induced

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84886935137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886935137&partnerID=8YFLogxK

U2 - 10.1007/s11886-013-0412-0

DO - 10.1007/s11886-013-0412-0

M3 - Article

VL - 15

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 11

M1 - 412

ER -